Search results (1052)
« Back to News
The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study
6 Oct, 2026
Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.
Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis
5 Oct, 2026
A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.
Robotic hip and knee surgery fails to cut overall risk of repeat surgery
1 Oct, 2026
Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.
Everyday DNA damage reveals a hidden weakness in some cancers
28 Sep, 2026
Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.
Dunn School publishes new children’s book to mark centenary
28 Sep, 2026
The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience
Researchers uncover genetic changes in the bacteria causing severe Kent meningococcal disease outbreak
25 Sep, 2026
The research, led by scientists at the Dunn School, the Biology Department, and the UK Health Security Agency, analysed the genome of bacteria that caused the outbreak, which affected 21 people in Kent during March this year.
Two-thirds of adults with high blood pressure do not know they have it
24 Sep, 2026
More than one-third of adults in England have high blood pressure and two-thirds of these are unaware of their diagnosis according to a new study of 1.4 million adults published in BMJ Public Health. The study also reported that only half of adults with high blood pressure treated by a doctor are adequately controlled.
Blood tests could identify early signs of cancer years before diagnosis
23 Sep, 2026
A study of blood samples collected up to nine years before a cancer diagnosis found changes in the DNA that captured the body’s response to early traces of cancer development.
Study sheds new light on how ketamine may act rapidly in the human brain
22 Sep, 2026
Researchers have identified a brain mechanism that could help explain ketamine’s unusually rapid antidepressant effects, providing new clues for the development of faster and potentially more targeted treatments for depression.
University of Oxford announces next-generation AI initiative to detect, assess and respond to pandemics
21 Sep, 2026
The University of Oxford has been awarded €8 million through the European Union’s Horizon Europe programme to coordinate the development of the Pandemics AI Observatory (PANDAI).
New method reveals how virus particles can build themselves, molecule by molecule
16 Sep, 2026
Oxford University researchers have captured the step-by-step assembly of individual virus-like particles, revealing how simple molecular interactions can reliably build these complex biological structures. The results have been published today in Nature.
New study charts the health of nearly 2 million UK adults in Our Future Health
10 Sep, 2026
A new study led by researchers at the Nuffield Department of Population Health’s Leverhulme Centre for Demographic Science has provided the first detailed picture of the health, lifestyle and disease patterns of participants in Our Future Health, a UK-wide research programme that is building the largest health data resource of its kind in the country. The study is published in Nature Medicine.
Adding rituximab to chemotherapy is a cost-effective treatment for Burkitt lymphoma
10 Sep, 2026
A new study led by researchers at the Nuffield Department of Population Health's Economics of Population Health Research Centre has found that adding rituximab, a high-cost cancer drug, to standard chemotherapy could be a cost-effective way to improve survival in children with Burkitt lymphoma, particularly those with advanced disease. The study is published in JCO Global Oncology.
Protecting brains and minds in a transition away from fossil fuels
10 Sep, 2026
Jessica Newberry Le Vay, Senior Researcher in climate change and child health from Department of Psychiatry, writes about new climate policy recommendations arising from the Transitioning Away from Fossil Fuels Conference
New GALENOS evidence-informed recommendations aim to improve equitable access to antipsychotic medicines for schizophrenia in low and middle-income countries
10 Sep, 2026
Global experts identify a prioritised set of antipsychotics to improve outcome of people with schizophrenia in Ethiopia, Nigeria, Rwanda and South Africa.
Study of almost one million adults links very hot drinks to threefold increase in oesophageal cancer risk
9 Sep, 2026
Drinking tea and coffee at a very hot temperature, rather than warm, is linked to a threefold increase in the risk of oesophageal squamous cell carcinoma, according to a new study by researchers at the Nuffield Department of Population Health’s Cancer Epidemiology Unit. The study is published in International Journal of Cancer.
UK maternal death rate 20% higher than in 2009–11, new MBRRACE-UK report finds
9 Sep, 2026
The latest Saving Lives, Improving Mothers’ Care report identifies persistent inequalities and pressures affecting maternity care and sets out new national recommendations alongside practical lessons to improve care for pregnant and recently pregnant women.
Carbon monoxide linked to lower Parkinson’s risk, opening potential new treatment pathway
8 Sep, 2026
A study of more than half a million adults has found that higher levels of exhaled carbon monoxide were associated with a lower risk of Parkinson’s disease. The findings, published in JAMA Neurology, uncover a possible new explanation for the consistently lower rates of Parkinson’s among smokers that have long puzzled scientists.
Building the world's evidence base to tackle drug-resistant tuberculosis
8 Sep, 2026
A new international programme, RESPECT-TB, coordinated by the Nuffield Department of Medicine at the University of Oxford in collaboration with the University of the Witwatersrand South Africa and Queen Mary University of London, will unite researchers and national tuberculosis programmes across five high-burden countries to build one of the world's richest evidence resources on drug-resistant tuberculosis (TB).
How body fat is stored across organs may reveal hidden health risks, study suggests
31 Aug, 2026
Researchers from the Nuffield Department of Population Health and the University of Oxford’s Big Data Institute have contributed to a new study showing that how fat accumulates in the body is just as important for identifying different health risks as a person’s overall weight.